Phase 2 clinical trial will be presented at the International Symposium on Intensive Care and Emergency Medicine (ISICEM) conference in Brussels, ...

See what stocks are receiving strong buy ratings from top-rated analysts. Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener. The latest ...

MiNK Therapeutics Inc (INKT) showcases promising clinical progress and strategic partnerships while navigating financial hurdles and leadership changes.

Vafidemstat has also been tested in a Phase II in severe Covid-19 patients (ESCAPE) assessing the capability of the drug to prevent ARDS, one of the most severe complications of the viral infection, ...

Hello, everyone, and welcome to MiNK Therapeutics fourth-quarter 2024 financial results call. Please note that this call is being recorded. (Operator Instructions) I'd now like to hand the call over ...

Hantaviruses, spread by rodents, cause severe illnesses like HPS; early detection and prevention are crucial for treatment ...

Ballinamallard manager Mark Stafford is looking for his side to be “more ruthless” in front of goal as they look to secure their NIFL Championship survival.

Oryzon has been invited to participate at the Van Lanschot Kempen Life Sciences Conference, which will take place in their offices located in Amsterdam (Netherlands) on April 1-3, where the company ...

The ongoing Phase 3 trial is utilizing vilobelimab dosed at 2400 ... circumstances for the treatment of adult patients with ...

The two remedies to red tide were developed under the $18 million Red Tide Mitigation Technology Initiative. Next: a pivot to ...

Hospital studies suggest that scrub typhus is a leading cause of severe undifferentiated fever in regions across Asia where the disease is endemic, but the population-based incidence of infection ...